Thyroid Medication–Associated Gastritis
Gastritis is not a typical direct adverse effect of levothyroxine or antithyroid drugs, but thyroid disorders and thyroid autoimmunity can be associated with chronic gastritis through shared autoimmune mechanisms. [1]
Antithyroid drugs (methimazole and propylthiouracil) more commonly cause nonspecific gastrointestinal symptoms (eg, nausea or abdominal discomfort), while gastritis is rarely described as a direct medication reaction. [2]
Levothyroxine and Autoimmune Gastritis
Autoimmune thyroid disease is associated with a higher prevalence of gastrointestinal autoimmune conditions, including chronic gastritis with atrophic features and intestinal metaplasia in some observational cohorts. [1]
In an endoscopy-based cohort of patients with hypothyroidism receiving thyroid replacement therapy, chronic gastritis was reported in most participants, along with duodenitis and other inflammatory findings. [1]
Levothyroxine, Dyspepsia, and Helicobacter pylori Context
Upper endoscopy studies evaluating levothyroxine treatment in hypothyroid patients with dyspepsia have included patients with Helicobacter pylori infection and have used endoscopy to characterize gastric findings. [3]
These data support an association between hypothyroidism/dyspepsia and gastric pathology evaluation during levothyroxine therapy, rather than demonstrating levothyroxine as a causal agent of gastritis. [3]
Antithyroid Drugs (Methimazole, Propylthiouracil) and GI Reactions
Methimazole has been reported in a case where a patient had concurrent gastritis while developing drug-induced liver injury, without establishing causality for gastritis. [2]
Such reports do not support gastritis as a common or well-established direct adverse effect of methimazole. [2]
Practical Clinical Implications
When new epigastric pain, burning, nausea, or vomiting occurs during thyroid medication therapy, evaluation for more common causes of gastritis (including Helicobacter pylori infection and medication-related dyspepsia from other agents) is appropriate. [3]
If autoimmune features are present (eg, established autoimmune thyroid disease), chronic gastritis and related conditions should be considered as comorbid diagnoses rather than assumed to be caused by thyroid replacement itself. [1]
Medication–Specific Bottom-Line Relationship
Levothyroxine: gastritis is more consistent with an association through autoimmune disease or coexisting gastric pathology than with a typical direct adverse effect of levothyroxine. [1]
Methimazole and propylthiouracil: gastritis is not established as a common direct adverse effect, and published evidence is largely limited to rare case-level descriptions involving concomitant gastritis. [2]
When to Escalate Care
Urgent assessment is recommended for gastrointestinal bleeding (hematemesis or melena), progressive anemia, unintentional weight loss, persistent vomiting, or severe persistent epigastric pain, since medication changes alone do not address potentially serious causes of gastritis-like symptoms.